|
1
|
Yu Y, Xu F, Peng H, et al: NOEY2 (ARHI),
an imprinted putative tumor suppressor gene in ovarian and breast
carcinomas. Proc Natl Acad Sci USA. 96:214–219. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herreros-Villanueva M, Hijona E, Cosme A
and Bujanda L: Spontaneous regression of pancreatic cancer: real or
a misdiagnosis? World J Gastroenterol. 18:2902–2908. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Strimpakos A, Saif MW and Syrigos KN:
Pancreatic cancer: from molecular pathogenesis to targeted therapy.
Cancer Metastasis Rev. 27:495–522. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hisatomi H, Nagao K, Wakita K and Kohno N:
ARHI/NOEY2 inactivation may be important in breast tumor
pathogenesis. Oncology. 62:136–140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu Z, Luo RZ, Lu Y, et al: The tumor
suppressor gene ARHI regulates autophagy and tumor dormancy in
human ovarian cancer cells. J Clin Invest. 118:3917–3929.
2008.PubMed/NCBI
|
|
6
|
Feng WU, Marquez R, Lu Z, Liu J, Lu KH,
Issa JP, Fishman DM, Yu Y and Bast RC Jr: Imprinted tumor
suppressor genes ARHI and PEG3 are the most frequently
down-regulated in human ovarian cancers by loss of heterozygosity
and promoter methylation. Cancer. 112:1489–1502. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weber F, Aldred MA, Morrison CD, et al:
Silencing of the maternally imprinted tumor suppressor ARHI
contributes to follicular thyroid carcinogenesis. J Clin Endocrinol
Metab. 90:1149–1155. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Riemenschneider MJ, Reifenberger J and
Reifenberger G: Frequent biallelic inactivation and transcriptional
silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors
with 1p loss. Int J Cancer. 122:2503–2510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Amaravadi RK: Autophagy-induced tumor
dormancy in ovarian cancer. J Clin Invest. 118:3837–3840.
2008.PubMed/NCBI
|
|
10
|
Lu X, Qian J, Yu Y, Yang H and Li J:
Expression of the tumor suppressor ARHI inhibits the growth of
pancreatic cancer cells by inducing G1 cell cycle arrest. Oncol
Rep. 22:635–640. 2009.PubMed/NCBI
|
|
11
|
Yang H, Lu X, Qian J, et al: Imprinted
tumor suppressor gene ARHI induces apoptosis correlated with
changes in DNA methylation in pancreatic cancer cells. Mol Med Rep.
3:581–587. 2010.PubMed/NCBI
|
|
12
|
Wickremasinghe RG, Prentice AG and Steele
AJ: p53 and Notch signaling in chronic lymphocytic leukemia: clues
to identifying novel therapeutic strategies. Leukemia.
25:1400–1407. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujioka S, Sclabas GM, Schmidt C,
Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C and Chiao
PJ: Function of nuclear factor kappaB in pancreatic cancer
metastasis. Clin Cancer Res. 9:346–354. 2003.PubMed/NCBI
|
|
14
|
Li Q and Verma IM: NF-kappaB regulation in
the immune system. Nat Rev Immunol. 2:725–734. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma X, Yang L, Xiao L, et al:
Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal
carcinoma cells via NF-κB regulated ATM expression. PLoS One.
6:e246472011.PubMed/NCBI
|
|
17
|
Perona R and Sánchez-Pérez I: Control of
oncogenesis and cancer therapy resistance. Br J Cancer. 90:573–577.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jung S, Yi L, Kim J, Jeong D, Oh T, Kim
CH, Kim CJ, Shin J, An S and Lee MS: The role of vimentin as a
methylation biomarker for early diagnosis of cervical cancer. Mol
Cells. 31:405–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Janssen EA, Øvestad I, Skaland I, Søiland
H, Gudlaugsson E, Kjellevold KH, Nysted A, Søreide JA and Baak JP:
LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast
cancer. Cell Oncol. 31:335–343. 2009.PubMed/NCBI
|
|
20
|
Freise C, Ruehl M, Erben U, et al: A
hepatoprotective Lindera obtusiloba extract suppresses
growth and attenuates insulin like growth factor-1 receptor
signaling and NF-kappaB activity in human liver cancer cell lines.
BMC Complement Altern Med. 11:392011.PubMed/NCBI
|
|
21
|
Edderkaoui M, Odinokova I, Ohno I,
Gukovsky I, Go VL, Pandol SJ and Gukovskaya AS: Ellagic acid
induces apoptosis through inhibition of nuclear factor kappa B in
pancreatic cancer cells. World J Gastroenterol. 14:3672–3680. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
MacKenzie L, McCall P, Hatziieremia S, et
al: Nuclear factor κB predicts poor outcome in patients with
hormone-naive prostate cancer with high nuclear androgen receptor.
Hum Pathol. 43:1491–1500. 2012.
|
|
23
|
Aggarwal BB and Sung B: NF-κB in cancer: a
matter of life and death. Cancer Discov. 1:469–471. 2011.
|
